100% satisfaction guarantee Immediately available after payment Both online and in PDF No strings attached
logo-home
Parkinsonism clinical summary $26.62   Add to cart

Summary

Parkinsonism clinical summary

 7 views  0 purchase
  • Course
  • Institution

Lecture notes on parkinsonism

Preview 1 out of 2  pages

  • June 8, 2021
  • 2
  • 2020/2021
  • Summary
avatar-seller
Parkinson’s disease
https://cks.nice.org.uk/topics/parkinsons-disease/ [NICE guideline ref]

Definition: chronic, progressive neurodegenerative condition resulting from the loss of the
dopamine-containing cells of the substantia nigra.
Parkinsonism is an umbrella term for the clinical syndrome involving bradykinesia together
with at least one of the following: rigidity, tremor, and postural instability.

Signs:
• Akinesia: the absence or reduction of movement
• Bradykinesia: the slowness of movement
• Rigidity: the resistance to passive movement
• Resting tremor

Complications:
 Motor complications (usually related to the use of anti-parkinsonian medication),
such as immobility, slowness, communication difficulties, motor fluctuations,
dyskinesia, and freezing of gait.
 Non-motor complications, such as depression, anxiety, impulse control disorders,
psychotic symptoms, dementia, sleep disturbance, autonomic dysfunction, falls, and
pain.


Management:
 Replace lost dopamine by giving L-DOPA, dopamine agonists, drugs that
reduce dopamine breakdown or reduce dopamine uptake
o Carbidopa, levodopa
o Effectiveness of L-DOPA decreases after 2-5 yrs as neurones still
degenerating
 Deep brain stimulation
 No treatments address the underlying degeneration of the neurones

 Alternatives to L-DOPA:
o Directly-acting dopamine receptor agonists
 Bromocriptine/Pergolide (fairly non-selective)
o Pramipexole/Ropinirole (more D2 receptor selective, newer)
 Apomorphine (reserved for advanced stage PD)
 Problems include: nausea/emetic effects, psychotomimetic
effects
o Drugs which inhibit breakdown of dopamine
 Selegiline (MAO-B inhibitor)
o Dopamine releaser
 Amantidine
o Muscarinic ACh receptor antagonists

The benefits of buying summaries with Stuvia:

Guaranteed quality through customer reviews

Guaranteed quality through customer reviews

Stuvia customers have reviewed more than 700,000 summaries. This how you know that you are buying the best documents.

Quick and easy check-out

Quick and easy check-out

You can quickly pay through credit card or Stuvia-credit for the summaries. There is no membership needed.

Focus on what matters

Focus on what matters

Your fellow students write the study notes themselves, which is why the documents are always reliable and up-to-date. This ensures you quickly get to the core!

Frequently asked questions

What do I get when I buy this document?

You get a PDF, available immediately after your purchase. The purchased document is accessible anytime, anywhere and indefinitely through your profile.

Satisfaction guarantee: how does it work?

Our satisfaction guarantee ensures that you always find a study document that suits you well. You fill out a form, and our customer service team takes care of the rest.

Who am I buying these notes from?

Stuvia is a marketplace, so you are not buying this document from us, but from seller ssazinnasuleman. Stuvia facilitates payment to the seller.

Will I be stuck with a subscription?

No, you only buy these notes for $26.62. You're not tied to anything after your purchase.

Can Stuvia be trusted?

4.6 stars on Google & Trustpilot (+1000 reviews)

79223 documents were sold in the last 30 days

Founded in 2010, the go-to place to buy study notes for 14 years now

Start selling
$26.62
  • (0)
  Add to cart